Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Flow-mediated dilation

From Wikipedia, the free encyclopedia

Flow-mediated dilation (FMD) refers to dilation of an artery when blood flow increases.[1][2][3] FMD is determined in humans using a noninvasive ultrasound assessment of the brachial artery.[3] It is a research indicator for endothelial function and possible diagnosis of cardiovascular diseases.[1][3] In laboratory research, release of nitric oxide by endothelial cells is a factor producing FMD.[3]

Method

[edit]

To determine FMD, brachial artery dilation following a transient period of forearm ischemia is measured using ultrasound.[3][4] Because the value of FMD can be compromised when improperly applied, a standardized method for measuring FMD is used.[3] The clinical value of FMD is limited by the fact that it is difficult to measure, requiring a skilled and well-trained clinician.[3]

Research

[edit]

FMD has been used as a noninvasive index of the function of resistance vessels and the capillary endothelium.[1][3][5] Low FMD is used as a potential predictor of future cardiovascular disease,[1][3] and as a possible biomarker for blood vessel disorders associated with chronic smoking.[6]

See also

[edit]

References

[edit]
  1. 1 2 3 4 Kelm M (2002). "Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects". American Journal of Physiology. 282 (1): H1–H5. doi:10.1152/ajpheart.2002.282.1.h1. PMID 11748041.
  2. ↑ Tremblay JC, Pyke KE (2018). "Flow-mediated dilation stimulated by sustained increases in shear stress: a useful tool for assessing endothelial function in humans?". American Journal of Physiology. Heart and Circulatory Physiology. 314 (3): H508–H520. doi:10.1152/ajpheart.00534.2017. PMC 5899264. PMID 29167121.
  3. 1 2 3 4 5 6 7 8 9 Thijssen DH, Black MA, Pyke KE, et al. (2011). "Assessment of flow-mediated dilation in humans: a methodological and physiological guideline". American Journal of Physiology. 300 (1): H2–H12. doi:10.1152/ajpheart.00471.2010. PMC 3023245. PMID 20952670.
  4. ↑ Montero D, Padilla J, Diaz-Cañestro C, et al. (2014). "Flow-mediated dilation in athletes: influence of aging". Medicine & Science in Sports & Exercise. 46 (11): 2148–2158. doi:10.1249/MSS.0000000000000341. PMID 24963792.
  5. ↑ Calderón-Gerstein WS, López-Peña A, Macha-Ramírez R, et al. (2017). "Endothelial dysfunction assessment by flow-mediated dilation in a high-altitude population". Vascular Health and Risk Management. 13: 421–426. doi:10.2147/VHRM.S151886. PMC 5701560. PMID 29200863.
  6. ↑ Messner B, Bernhard D (2014). "Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis". Arteriosclerosis, Thrombosis, and Vascular Biology. 34 (3): 509–515. doi:10.1161/ATVBAHA.113.300156. PMID 24554606.